We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
+32.74%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$115M
AUM Growth
–
Cap. Flow
+$94.2M
Cap. Flow %
82.11%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$54.3M
2
LUNG icon
Pulmonx
LUNG
+$39.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVL
1
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$58.5M 50.97%
+77,719
New +$54.3M
LUNG icon
2
Pulmonx
LUNG
$87.6M
$56.3M 49.03%
+815,019
New +$39.9M

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
IWM
Immaculate Wealth Management Mesa, Arizona $12.7M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for ABG-WTT Global Life Science Capital Partners, which disclosed 2 positions worth $115M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is MedAvail Holdings, Inc. Common Stock: 77,719 shares worth $58.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • ABG-WTT Global Life Science Capital Partners's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 77,719 shares worth $58.5M.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $115M portfolio in Q4 2020.
  • ABG-WTT Global Life Science Capital Partners disclosed 2 positions in Q4 2020, its first 13F filing on record.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.